Imiquimod as neoadjuvant treatment for giant keratoacanthoma arising on a background of lupus vulgaris

Clin Exp Dermatol. 2014 Jan;39(1):60-2. doi: 10.1111/ced.12184. Epub 2013 Jun 18.

Authors

M Tsikeloudi¹, A Lallas, T Sidiropoulos, V Chasioti, I Lefaki, Z Apalla

Affiliation

¹ State Clinic of Dermatology, Hospital of Skin and Venereal Diseases, 124, Delfon Street, Thessaloniki, Greece.

PMID: 23773180
DOI: 10.1111/ced.12184

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Aged
Aminoquinolines / therapeutic use*
Antineoplastic Agents / therapeutic use*
Chemotherapy, Adjuvant
Facial Dermatoses / drug therapy*
Facial Dermatoses / pathology
Humans
Imiquimod
Keratoacanthoma / drug therapy*
Keratoacanthoma / pathology
Lupus Vulgaris / complications*
Male
Treatment Outcome

Substances

Aminoquinolines
Antineoplastic Agents
Imiquimod